Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Healthequity (HQY)

Healthequity (HQY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,728,698
  • Shares Outstanding, K 86,663
  • Annual Sales, $ 999,590 K
  • Annual Income, $ 55,710 K
  • EBIT $ 267 M
  • EBITDA $ 423 M
  • 60-Month Beta 0.62
  • Price/Sales 7.75
  • Price/Cash Flow 28.49
  • Price/Book 3.97

Options Overview Details

View History
  • Implied Volatility 47.90% ( +2.76%)
  • Historical Volatility 33.18%
  • IV Percentile 93%
  • IV Rank 65.80%
  • IV High 59.76% on 03/10/25
  • IV Low 25.10% on 06/20/24
  • Put/Call Vol Ratio 0.55
  • Today's Volume 269
  • Volume Avg (30-Day) 185
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 3,176
  • Open Int (30-Day) 2,837

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/25
See More
  • Average Estimate 0.51
  • Number of Estimates 6
  • High Estimate 0.55
  • Low Estimate 0.48
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +2.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.60 +10.25%
on 03/10/25
115.22 -12.35%
on 02/19/25
-12.25 (-10.82%)
since 02/18/25
3-Month
91.60 +10.25%
on 03/10/25
115.59 -12.63%
on 02/13/25
+9.45 (+10.32%)
since 12/18/24
52-Week
65.01 +55.35%
on 08/05/24
115.59 -12.63%
on 02/13/25
+18.03 (+21.73%)
since 03/18/24

Most Recent Stories

More News
HealthEquity Assistâ„¢: A new suite of integrated benefit solutions that drive deeper engagement, deliver cost savings, and increase transparency for employee benefits

HQY : 101.08 (+0.36%)
HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle

HQY : 101.08 (+0.36%)
Forbes and U.S. News & World Report Agree: HealthEquity is One of America’s Best Places to Work

HQY : 101.08 (+0.36%)
The Path Forward: How Commuting Impacts the Return to Office Experience

HQY : 101.08 (+0.36%)
HealthEquity Reports Year-End Sales Metrics

HQY : 101.08 (+0.36%)
Tech-Powered Innovation Transforms Member Experiences and Earns HealthEquity Industry Recognition

HQY : 101.08 (+0.36%)
HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference

HQY : 101.08 (+0.36%)
HealthEquity Caps 2024 With Widespread Recognition For Its Workplace Excellence

HQY : 101.08 (+0.36%)
Insider Sale: Director at $HQY (HQY) Sells 2,500 Shares

ROBERT W SELANDER, a director at $HQY ($HQY), sold 2,500 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.4% of their shares....

HQY : 101.08 (+0.36%)
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat

HealthEquity, Inc. HQY reported adjusted earnings per share (EPS) of 78 cents in third-quarter fiscal 2025, surpassing the Zacks Consensus Estimate by 9.86%. The bottom line improved 30% on a year-over-year...

AXGN : 17.66 (-3.39%)
HQY : 101.08 (+0.36%)
ARAY : 1.8250 (-2.41%)
MASI : 169.50 (-1.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial...

See More

Key Turning Points

3rd Resistance Point 106.03
2nd Resistance Point 103.46
1st Resistance Point 102.09
Last Price 101.08
1st Support Level 98.15
2nd Support Level 95.58
3rd Support Level 94.21

See More

52-Week High 115.59
Last Price 101.08
Fibonacci 61.8% 96.27
Fibonacci 50% 90.30
Fibonacci 38.2% 84.33
52-Week Low 65.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar